We are live on ! Find out more
REGN icon

Regeneron Pharmaceuticals
REGN

371 hedge funds and large institutions have $17B invested in Regeneron Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 371 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more call options, than puts

Call options by funds: $300M | Put options by funds: $263M

Holders
371
Holders Change
+371
Holders Change %
–
% of All Funds
12.11%
Holding in Top 10
9
Holding in Top 10 Change
+9
Holding in Top 10 Change %
% of All Funds
0.29%
New
371
Increased
–
Reduced
–
Closed
–
Calls
$300M
Puts
$263M
Net Calls
+$37.1M
Net Calls Change
+$37.1M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
26
Wells Fargo
California
$88.1M +$91.3M +391,909 New
JHIU
27
Janus Henderson Investors US
Colorado
$85.2M +$88.2M +378,951 New
UBS AM
28
UBS AM
Illinois
$79.4M +$82.3M +353,269 New
O
29
OrbiMed
New York
$79M +$81.8M +351,100 New
BA
30
BlackRock Advisors
Delaware
$73.6M +$76.2M +327,158 New
Calamos Advisors
31
Calamos Advisors
Illinois
$72.5M +$75.1M +322,526 New
TCIM
32
TIAA CREF Investment Management
New York
$67.5M +$69.9M +300,132 New
Legal & General Group
33
Legal & General Group
United Kingdom
$66.9M +$69.3M +297,704 New
Adage Capital Partners
34
Adage Capital Partners
Massachusetts
$66.3M +$68.6M +294,770 New
CS
35
Credit Suisse
Switzerland
$63.9M +$66.2M +284,356 New
Massachusetts Financial Services
36
Massachusetts Financial Services
Massachusetts
$63.7M +$65.9M +283,183 New
SGA
37
Sustainable Growth Advisers
Connecticut
$63.4M +$65.6M +281,721 New
TCM
38
Tekla Capital Management
Massachusetts
$62.9M +$65.1M +279,759 New
SAM
39
Sectoral Asset Management
Quebec, Canada
$61.8M +$64M +274,666 New
RFS
40
Rockefeller Financial Services
New York
$60.1M +$62.3M +267,379 New
STC
41
SEI Trust Company
Pennsylvania
$55M +$56.9M +244,521 New
Renaissance Technologies
42
Renaissance Technologies
New York
$52.8M +$54.7M +234,762 New
RFC
43
Russell Frank Company
Washington
$52M +$49.2M +211,323 New
Morgan Stanley
44
Morgan Stanley
New York
$51.8M +$53.6M +230,223 New
New York State Common Retirement Fund
45
New York State Common Retirement Fund
New York
$50.8M +$52.6M +225,674 New
Two Sigma Investments
46
Two Sigma Investments
New York
$48.5M +$50.2M +215,680 New
Sumitomo Mitsui Trust Group
47
Sumitomo Mitsui Trust Group
Japan
$45.8M +$47.4M +203,744 New
GC
48
Guggenheim Capital
Illinois
$45.3M +$46.9M +201,525 New
First Trust Advisors
49
First Trust Advisors
Illinois
$43.1M +$44.7M +191,837 New
Two Sigma Advisers
50
Two Sigma Advisers
New York
$42.4M +$43.9M +188,680 New
1
2
3 4 5

REGN Hedge Fund Activity: Q2 2013 in Review

371 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Regeneron Pharmaceuticals (REGN) for Q2 2013, worth a combined $17B.

Buyers outnumbered sellers: 371 funds opened new REGN positions and 0 closed out — a net gain of 371 holders — while 0 added to existing stakes and 0 trimmed.

  • 371 institutional investors held Regeneron Pharmaceuticals (REGN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $17B of Regeneron Pharmaceuticals stock for Q2 2013.
  • 371 funds opened new Regeneron Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +371 holders.

Based on aggregated 13F filings for Q2 2013.